New York State Common Retirement Fund Silverback Therapeutics, Inc. Transaction History
New York State Common Retirement Fund
- $74.9 Billion
- Q3 2025
A detailed history of New York State Common Retirement Fund transactions in Silverback Therapeutics, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 17,707 shares of SBTX stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,707
Previous 93,298
81.02%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
23 transactions
Others Institutions Holding SBTX
# of Institutions
209Shares Held
84.3MCall Options Held
1.21MPut Options Held
687K-
Ra Capital Management, L.P. Boston, MA10.9MShares$00.0% of portfolio
-
Orbimed Advisors LLC San Diego, CA8.29MShares$00.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY7.5MShares$00.0% of portfolio
-
Rubric Capital Management LP New York, NY4.5MShares$00.0% of portfolio
-
Black Rock Inc. New York, NY4.08MShares$00.0% of portfolio
About Silverback Therapeutics, Inc.
- Ticker SBTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,473,800
- Description
- Silverback Therapeutics, Inc., a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver. Silverba...